Journal profile · Medicine-Pulmonary and Respiratory Medicine
Chinese Journal of Lung Cancer
ISSN 1009-3419 · eISSN 1999-6187 · Chinese Anticancer Association · China
Chinese Journal of Lung Cancer: fully open access; APC charged, amount not published; review about 14 weeks (community reports); indexed in Scopus.
Scope
Aims, scope and focus
Chinese Journal of Lung Cancer is published by Chinese Anticancer Association. By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment and Lung Cancer Treatments and Mutations, together about 59.5% of its articles. Its main subfields are Oncology and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Chinese Journal of Lung Cancer(CJLC, pISSN 1009-3419, eISSN 1999-6187, CN 12-1395/R), a monthly OA journal, is hosted by Chinese Anti-Cancer Association, Chinese Antituberculosis Association, Tianjin Medical University General Hospital. CJLC was established in 1998 and indexed in DOAJ, EMBASE/SCOPUS, CA, AJ-VINITI, WANFANG, etc. CJLC aims to publish original laboratory and clinical investigations related to lung cancer.. The Journal publishes editorials, perspectives, original research, review articles, short communications, case reports on clinical and basic science aspects of topics represented by the fields of Lung Cancer (prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, etc).
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pulmonary and Respiratory Medicine
Editor-in-chief Qinghua ZhouPublisher website
Editorial board by country: 117 in mainland China (about 81%); most named Mainland China 117, United States 22, Hong Kong, China 3, Taiwan, China 1, Japan 1 (145 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Research StudiesMedicine22.8%
- Lung Cancer Diagnosis and TreatmentMedicine22.6%
- Lung Cancer Treatments and MutationsMedicine14.1%
- Mechanisms of cancer metastasisBiochemistry, Genetics and Molecular Biology6.6%
- Cancer Cells and MetastasisMedicine3.5%
- Cancer-related Molecular PathwaysMedicine2.7%
- Medical Imaging Techniques and ApplicationsMedicine2.2%
- Metastasis and carcinoma case studiesMedicine2.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | Q3 | 116/165 | 30th |
| Oncology | Q3 | 303/428 | 29th |
| Cancer Research | Q4 | 194/233 | 16th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.31LetPub ·
- SNIP 2026-06
- 0.28LetPub ·
- h-index
- 3OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 501 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2024 | 0 | 0 | 2 |
| 2023 | 0 | 0 | 2 |
| 2022 | 0 | 0 | 5 |
| 2021 | 0 | 0 | 5 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CNY 1,000 | Yes | CC BY |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review, Plagiarism
- Open access Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Source ↗Publisher website ·- Peer review Peer Review Process
Only manuscripts of high relevance and suitability will enter into the peer review process, which will be conducted by at least two internationally known experts in the field, and will aim to ensure that all published manuscripts provide new scientific knowledge. Authors may suggest that specific individuals be or not be involved as reviewers, but the final decision of acceptance or rejection rest…
Source ↗Publisher website ·- Plagiarism Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, which this has been appropriately cited or quoted. Plagiarism takes many forms, such as using someone else’s language, ideas, or other original (not common-knowledge) material without acknowledging its source. Definition:Plagiarism has been traditionally defined a…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Chinese Anticancer Association
- Country or region
- China
- Language
- Chinese
- ISSN
- 1009-3419
- Electronic ISSN
- 1999-6187
- Official links
FAQ
Frequently asked questions about Chinese Journal of Lung Cancer
How long does peer review take at Chinese Journal of Lung Cancer?
Authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Chinese Journal of Lung Cancer based?
Of the 145 board members whose country the journal's board page names, 117 (about 81%) are in mainland China; the countries named most often are Mainland China (117), United States (22) and Hong Kong, China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Chinese Journal of Lung Cancer?
According to LetPub and DOAJ records, Chinese Journal of Lung Cancer is indexed in Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Chinese Journal of Lung Cancer open access, and what is the APC?
Chinese Journal of Lung Cancer is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .